Skip to main content

Table 2 Groups of transplanted hematopoietic stem cells

From: Rhinosinusitis in hematopoietic stem cell-transplanted patients: influence of nasosinus mucosal abnormalities?

 

HSCT

Hematologic disease

GVHD

With rhinosinusitis

Myeloablative: 16 (66%)

CML: 5 (21%)

With: 16 (66%)

AML: 5 (21%)

Nonmyeloablative: 8 (33%)

MM: 3 (12.5%)

Without: 8 (33%)

CLL: 1 (4%)

AA: 3 (12.5%)

MDS: 4 (17%)

ALL: 2 (8%)

SCA: 1 (4%)

Without rhinosinusitis

Myeloablative: 6 (100%)

ALL: 1 (17%)

With: 5 (83%)

CML: 3 (50%)

 

AML: 1 (17%)

Without: 1 (17%)

  

AA: 1 (17%)

 
  1. AA, aplastic anemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia; GVHD, graft versus host disease; HSCT, hematopoietic stem cell transplant; MDS, myelodysplastic syndrome; MM, multiple myeloma; SCA, sickle cell anemia.
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512